Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients
Open Access
- 21 December 2016
- journal article
- research article
- Published by Wiley in Journal of Immunology Research
- Vol. 2016, 1-8
Abstract
The presented article studies the role of selected inflammatory and anti-inflammatory serum markers of psoriatic patients in the pathogenesis of metabolic syndrome (MS) and psoriasis. The study is based on the comparison between the group of psoriatic patients (74) and the control group (65). We found significantly higher BMI () and diastolic blood pressure () in the psoriatic patients. The values of waist circumference and BMI were significantly higher () in the male patients compared to the men in the control group. The analysis revealed significantly higher CRP (), Lp-PLA2 (), leptin (), and resistin () levels in the psoriatic patients. Significantly higher levels of CRP (), Lp-PLA2 (), leptin (), and resistin () were found in the patients with MS compared to the controls with MS. The level of adiponectin was significantly lower () in the patients with MS. Finally, we found significantly higher level of Lp-PLA2 () in the group of patients without MS compared to the controls without MS. In conclusion, observed inflammatory and anti-inflammatory markers (CRP, adiponectin, leptin, resistin, and Lp-PLA2) are involved in both pathogenesis of MS and pathogenesis of psoriasis. The level of Lp-PLA2 indicates the presence of subclinical atherosclerosis (cardiovascular risk) in psoriatic patients.
Keywords
Funding Information
- Univerzita Karlova v Praze (PRVOUK P37/09, PRVOUK P37/10)
- Univerzita Karlova v Praze (PRVOUK P37/09, PRVOUK P37/10)
This publication has 63 references indexed in Scilit:
- C‐reactive protein in psoriasis: a review of the literatureJournal of the European Academy of Dermatology and Venereology, 2013
- Association of psoriasis with stroke and myocardial infarction: meta‐analysis of cohort studiesBritish Journal of Dermatology, 2012
- Serum leptin, adiponectin, resistin and ghrelin levels in psoriatic patients treated with cyclosporinThe Journal of Dermatology, 2012
- Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapyJournal of the European Academy of Dermatology and Venereology, 2010
- Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.British Journal of Dermatology, 2010
- Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studiesThe Lancet, 2010
- Psoriasis and the metabolic syndromeDermatologic Therapy, 2010
- Adipose tissue as an endocrine organMolecular and Cellular Endocrinology, 2010
- The role of resistin as a regulator of inflammation: Implications for various human pathologiesClinical Immunology, 2009
- Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammationBritish Journal of Dermatology, 2008